TransEnterix (TRXC) to Feature Senhance System at ACS Clinical Congress 2016

October 13, 2016 6:56 AM EDT
Get Alerts TRXC Hot Sheet
Trade TRXC Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

TransEnterix, Inc. (NYSE: TRXC) announced that it will exhibit and feature the Senhance Surgical Robot (“the Senhance” or “the Senhance system”) at the Clinical Congress 2016 of the American College of Surgeons (ACS). The congress will be held on October 16-20, 2016 in Washington, DC.

“ACS is the largest gathering of global surgeons, and we are pleased to bring the Senhance System to exhibit at this major meeting for the first time,” said Mohan Nathan, Vice President of Global Marketing at TransEnterix. “General surgical interest in the use of robotics is rapidly expanding, and the next wave of adoption will be driven by providing surgeons with new capabilities. Senhance is the first system that brings haptic force feedback, eye-sensing camera control, and responsible economics through reusable instrumentation to robotics.”

The Senhance will be available for surgeon evaluations at the congress. Surgeons may schedule system evaluations by signing up at the TransEnterix booth. Non-surgeons may see demonstrations throughout the conference, and may also attend a group demonstration at the booth at 10am on Tuesday, October 18, 2016.

The Senhance carries the CE Mark for use in general surgery, gynecology, urology and thoracic surgery but is not available for sale in the US. TransEnterix is preparing a submission for U.S. FDA Clearance for the Senhance.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment